Henry Schein Raises Revolving Credit to $1.25B

Key prior events and disclosures relevant to this facility expansion: - October 2023: A cybersecurity incident disrupted North American and European dental and medical distribution operations; filings note ongoing insurance recoveries and SG&A impacts tied to that event. - 2025: Strategic and financing milestones include the TriMed acquisition (reported net assets of $315 million) and a $250 million investment from KKR (roughly 12% ownership post-transaction). - 2025 securitization: U.S. receivables securitization programs were reported in the $400M–$492M range, where the parent retains recourse. - Q2 2025 filings: Contingent consideration and other liabilities (e.g., $106M contingent consideration) were disclosed alongside impairment and litigation items. - 2026-07-30: Key executives transitioned to advisory roles per the historical timeline provided; prior filings had noted the board expected to name a new CEO by mid‑January 2026. The expanded revolving facility announced on 2026-09-22 should be read against these events: it increases committed liquidity through 2031 and aligns with management’s stated focus on distribution, technology and selective M&A under the DOL +1 framework.